PTH-related protein upregulates integrin α6β4 expression and activates Akt in breast cancer cells

Experimental Cell Research

Volumn 312, Issue 19, 2006, Pages 3822-3834

  Shen, Xiaoli ^a   Falzon, Miriam ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Akt; Breast cancer; GSK 3; Integrin 6 4; Parathyroid hormone related protein

Indexed keywords

ALPHA6 INTEGRIN; BETA4 INTEGRIN; GLYCOGEN SYNTHASE KINASE 3; MESSENGER RNA; PARATHYROID HORMONE RELATED PROTEIN; PROTEIN KINASE B; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; UPREGULATION;

EID: 33750375537     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.08.011     Document Type: Article

References (63)

1. Mercurio A.M., Bachelder R.E., Chung J., O'Connor K.L., Rabinovitz I., Shaw L.M., and Tani T.M. Integrin laminin receptors and breast carcinoma progression. J. Mammary Gland Biol. Neoplasia 6 (2001) 299-309
2. Goltzman D. Mechanisms of development of osteoblastic metastases. Cancer (Suppl.) 80 (1997) 1581-1587
3. Kohn E.C., and Liotta L.A. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res. 55 (1995) 1856-1862
4. Yoneda T., Sasaki A., and Mundy G.R. Osteolytic bone metastasis in breast cancer. Breast Cancer Res. Treat. 32 (1994) 73-84
5. Guise T.A. Molecular mechanisms of osteolytic bone metastases. Cancer 88 (2000) 2892-2898 (Suppl.)
6. Guise T.A., Yin J.J., Taylor S.D., Kumagai Y., Dallas M., Boyce B.F., Yoneda T., and Mundy G.R. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J. Clin. Invest. 98 (1996) 1544-1549
7. Strewler G.I. Mechanisms of disease: the physiology of parathyroid hormone-related protein. N. Engl. J. Med. 342 (2000) 177-185
8. Philbrick W.M., Wysolmerski J.J., Galbraith S., Holt E., Orloff J.J., Yang K.H., Vasavada R.C., Weir E.C., Broadus A.E., and Stewart A.F. Defining the role of parathyroid hormone-related protein in normal physiology. Physiol. Rev. 76 (1996) 127-173
9. de Papp A.E., Yang K.H., Soifer N.E., and Stewart A.F. Parathyroid hormone-related protein as a prohormone: posttranslational processing and receptor interaction. In: Negro-Villar A. (Ed). Endocrine Review Monograph Series vol. A4 (1995) 207-210
10. Mannstadt M., Jüppner H., and Gardella T.J. Receptors for PTH and PTHrP. Am. J. Physiol. 277 (1999) F665-F675
11. Jüppner H., Abou-Samra A.-B., Freeman M., Kong X.F., Schipani E., Richards J., Kolakowski Jr. L.F., Hock J., Potts Jr. J.T., Kronenberg H.M., and Segre G.V. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254 (1991) 1024-1026
12. Kaiser S.M., Sebag M., Rhim J.S., Kremer R., and Goltzman D. Antisense-mediated inhibition of parathyroid hormone-related peptide production in a keratinocyte cell line impedes differentiation. Mol. Endocrinol. 8 (1994) 139-147
13. Henderson J.E., Amikuza N., Warshawsky H., Biasotto D., Lanske B.M.K., Goltzman D., and Karaplis A.C. Nucleolar localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death. Mol. Cell. Biol. 15 (1995) 4064-4075
14. Tovar Sepulveda V.A., Shen X., and Falzon M. Intracrine parathyroid hormone-related protein protects against serum starvation-induced apoptosis and regulates the cell cycle in MCF-7 breast cancer cells. Endocrinology 143 (2002) 596-606
15. Shen X., Qian L., and Falzon M. PTH-related protein enhances MCF-7 breast cancer cell adhesion, migration, and invasion via an intracrine pathway. Exp. Cell Res. 294 (2004) 420-433
16. Wysolmerski J.J., Philbrick W.M., Dunbar M.E., Lanske B., Kronenberg H., and Broadus A.E. Rescue of the parathyroid hormone-related protein knockout mouse demonstrates that parathyroid hormone-related protein is essential for mammary gland development. Development 125 (1998) 1285-1294
17. Grill V., Hillary J., Ho P.M., Law F.M., MacIsaac R.J., MacIsaac I.A., Moseley J.M., and Martin T.J. Parathyroid hormone-related protein: a possible endocrine function in lactation. Clin. Endocrinol. 37 (1992) 405-410
18. Guise T.A., and Mundy G.R. Cancer and bone. Endocr. Rev. 19 (1998) 18-54
19. Grill V., Ho P., Body J.J., Johanson N., Lee S.C., Kukreja S.C., Moseley J.M., and Martin T.J. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer. J. Clin. Endocrinol. Metab. 73 (1991) 1309-1315
20. Southby J., Kissin M.W., Danks J.A., Hayman J.A., Moseley J.M., Henderson M.A., Bennett R.C., and Martin T.J. Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer. Cancer Res. 50 (1990) 7710-7716
21. Iezzoni J.C., Bruns M.E., Frierson H.F., Scott M.G., Pence R.A., Deftos L.J., and Bruns D.E. Coexpression of parathyroid hormone-related protein and its receptor in breast carcinoma: a potential autocrine effector system. Modern Path. 11 (1998) 265-270
22. Kissin M.W., Henderson M.A., Danks J.A., Hayman J.A., Bennett R.C., and Martin T.J. Parathyroid hormone-related protein in breast cancers of widely varying prognosis. Eur. J. Surg. Oncol. 19 (1993) 134-142
23. Edwards R.C., Ratcliffe W.A., Walls J., Morrison J.M., Ratcliffe J.G., Holder R., and Bundred N.J. Parathyroid hormone-related protein (PTHrP) in breast cancer and benign breast tissue. Eur. J. Cancer 31A (1995) 334-339
24. Shen X., and Falzon M. PTH-related protein modulates prostate cancer cell adhesion and integrin subunit profile. Mol. Cell. Endocrinol. 199 (2003) 165-177
25. Shen X., and Falzon M. PTH-related protein enhances LoVo colon cancer cell proliferation, adhesion, and integrin expression. Regul. Pept. 125 (2005) 17-27
26. Mercurio A.M. Receptors for the laminins. Achieving specificity through cooperation. Trends Cell Biol. 5 (1995) 419-423
27. Chao C., Lotz M.M., Clarke A.C., and Mercurio A.M. A function for the integrin alpha6beta4 in the invasive properties of colorectal carcinoma cells. Cancer Res. 56 (1996) 4811-4819
28. Shaw L.M., Rabinovitz I., Wang H.H., Toker A., and Mercurio A.M. Activation of phosphoinositide-3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion. Cell 91 (1997) 949-960
29. O'Connor K.L., Shaw L.M., and Mercurio A.M. Release of cAMP gating by the alpha6beta4 integrin stimulates lamellae formation and the chemotactic migration of invasive carcinoma cells. J. Cell Biol. 143 (1998) 1749-1760
30. Rabinovitz I., and Mercurio A.M. The integrin alpha6beta4 functions in carcinoma cell migration on laminin-1 by mediating the formation and stabilization of actin-containing motility structures. J. Cell Biol. 139 (1997) 1873-1884
31. Rabinovitz I., Toker A., and Mercurio A.M. Protein kinase C-dependent mobilization of the alpah6beta4 integrin from hemidesmosomes and its association with actin-rich cell protrusions drive the chemotactic migration of carcinoma cells. J. Cell Biol. 146 (1999) 1147-1160
32. Rabinovitz I., Gibson I.K., and Mercurio A.M. Traction forces mediated by alpha6beta4 integrin: implications for basement membrane organization and tumor invasion. Mol. Cell. Biol. 12 (2001) 4030-4043
33. Chung J., Bachelder R.E., Lipscomb E.A., Shaw L.M., and Mercurio A.M. Integrin alpha6beta4 regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. J. Cell Biol. 158 (2002) 165-174
34. Hemler M.E., Crouse C., and Sonnenberg A. Association of the VLA alpha 6 subunit with a novel protein. A possible alternative to the common VLA beta 1 subunit on certain cell lines. J. Biol. Chem. 264 (1989) 6529-6535
35. Falcioni R., Sacchi A., Resau J., and Kennel S.J. Monoclonal antibody to human carcinoma-associated protein complex: quantitation in normal and tumor tissue. Cancer Res. 48 (1988) 816-821
36. Guise T.A., Yin J.J., Thomas R.J., Dallas M., Cui Y., and Gillespie M.T. Parathyroid hormone-related protein (PTHrP)-(1-139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo. Bone 5 (2002) 670-676
37. Thomas R.J., Guise T.A., Yin J.J., Elliot J., Horwood N.J., Martin T.J., and Gillespie M.T. Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology 140 (1999) 4451-4458
38. Yin J., Selander K., Chirgwin J.M., Dallas M., Grubbs B.G., Weiser R., Massagué J., Mundy G.R., and Guise T.A. TGFβ signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J. Clin. Invest. 103 (1999) 197-206
39. Lindemann R.K., Ballschmieter P., Nordheim A., and Dittmer J. Transforming growth factor β regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad/Ets synergism. J. Biol. Chem. 276 (2001) 46661-46670
40. Käkönen M., Selander K.S., Chirgwin J.M., Yin J.J., Burns S., Rankin W.A., Grubbs B.G., Dallas M., Cui Y., and Guise T.A. Transforming growth factor-β stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways. J. Biol. Chem. 277 (2002) 24571-24578
41. Liapis H., Crouch E.C., Grosso L.E., Kitazawa S., and Wick M.R. Expression of parathyroid like protein in normal, proliferative and neoplastic human breast tissues. Am. J. Pathol. 143 (1993) 1169-1178
42. Birch M.A., Carron J.A., Scott M., Fraser W.D., and Gallagher J.A. Parathyroid hormone (PTH)/PTH-related protein (PTHrP) receptor expression and mitogenic responses in human breast cancer cell lines. Br. J. Cancer 72 (1995) 90-95
43. Carron J.A., Fraser W.D., and Gallagher J.A. PTHrP and the PTH/PTHrP receptor are co-expressed in human breast cancer and colon tumours. Br. J. Cancer 76 (1997) 1095-1098
44. Guise T.A., and Mundy G.R. Cancer and bone. Endocr. Rev. 19 (1998) 18-54
45. Ruoslahti E. Integrins. J. Clin. Invest. 87 (1991) 1-5
46. Ruoslahti E., Noble N.A., Kagami S., and Border W.A. Integrins. Kidney Int. 45 Suppl. 44 (1994) S17-S22
47. Lipscomb E.A., and Mercurio A.M. Mobilization and activation of a signaling component α6β4 integrin underlies its contribution to carcinoma progression. Cancer Metastasis Rev. 24 (2005) 413-423
48. Tamura R.N., Rozzo C., Starr L., Chambers J., Reichardt L.F., Cooper H.M., and Quaranta V. Epithelial integrin alpha6beta4: complete primary structure of alpha6 and variant forms of beta4. J. Cell Biol. 111 (1990) 1593-1604
49. Rabinovitz I., and Mercurio A.M. The integrin alpha6beta4 and the biology of carcinoma. Biochem. Cell Biol. 74 (1996) 811-821
50. Mercurio A.M., and Rabinovitz I. Towards a mechanistic understanding of tumor-invasion-Lessons from the alpha6beta4 integrin. Semin. Cancer Biol. 11 (2001) 129-141
51. Sun H., Santoro S.A., and Zutter M.M. Downstream events in mammary gland morphogenesis mediated by reexpression of the α2β1 integrin: the role of the α6 and β4 integrin subunits. Cancer Res. 58 (1998) 2224-2233
52. Lipscomb E.A., Dugan A.S., Rabinovitz I., and Mercurio A.M. Use of RNA interference to inhibit integrin (α6β4)-mediated invasion and migration of breast carcinoma cells. Clin. Exp. Metastasis 20 (2003) 569-576
53. Shaw L.M., Chao C., Wewer U.M., and Mercurio A.M. Function of the integrin α6β1 in metastatic breast carcinoma cells assessed by expression of a dominant negative receptor. Cancer Res. 56 (1996) 959-963
54. Shaw L.M. Integrin function in breast carcinoma progression. J. Mammary Gland Biol. Neoplasia 4 (1999) 367-376
55. Friedrichs K., Ruiz P., Franke F., Gille I., Terpe H.J., and Imhof B.A. High expression level of α6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res. 55 (1995) 901-906
56. Tagliabue E., Ghirelli C., Squicciarini P., Aiello P., Colnaghi M.I., and Menard S. Prognostic value of α6β4 integrin expression in breast carcinomas is affected by laminin production from tumor cells. Clin. Cancer Res. 4 (1998) 407-410
57. Bachelder R.E., Ribick M.J., Marchetti A., Falcioni R., Soddu S., Davis K.R., and Mercurio A.M. p53 inhibits alpha6beta4 integrin survival signaling by promoting the caspase 3-dependent cleavage of AKT/PKB. J. Cell Biol. 147 (1999) 1063-1072
58. Dittmer A., Vetter M., Schunke D., Span P.N., Sweep F., Thomssen C., and Dittmer J. Parathyroid hormone-related protein regulates tumor-relevant genes in breast cancer cells. J. Biol. Chem. 281 (2006) 14563-14572
59. Falcioni R., Antonini A., Nistico P., DiStefano S., Crescenzi M., Natali P.G., and Sacchi A. Alpha6beta4 and alpha6beta1 integrins associate with ErbB-2 in human carcinoma cell lines. Exp. Cell Res. 236 (1997) 76-85
60. Trusolino L., Bertotti A., and Comoglio P.M. A signaling adapter function for alpha6beta4 in the control of HGF-dependent invasive growth. Cell 107 (2001) 643-654
61. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
62. Sable C.L., Filippa N., Hemmings B., and Van Obberghen E. cAMP stimulates protein kinase B in a Wortmannin-insensitive manner. FEBS Lett. 409 (1997) 253-257
63. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., and Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 (1995) 785-789